Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Cox DG"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 42
Tytuł:
Efficacity of Deep Inspiration Breath Hold and Intensity-Modulated Radiotherapy in Preventing Perfusion Defect for Left Sided Breast Cancer (EDIPE): A Prospective Cohort Study Protocol.
Autorzy:
Eber J; Department of Radiation Oncology, Institut de Cancérologie Strasbourg Europe (ICANS), 17 Rue Albert Calmette, BP 23025, 67033 Strasbourg, France.
Blondet C; Department of Nuclear Medicine, Institut de Cancérologie Strasbourg Europe (ICANS), 17 Rue Albert Calmette, BP 23025, 67033 Strasbourg, France.
Schmitt M; Department of Radiation Oncology, Institut de Cancérologie Strasbourg Europe (ICANS), 17 Rue Albert Calmette, BP 23025, 67033 Strasbourg, France.
Cox DG; Department of Nuclear Medicine, Institut de Cancérologie Strasbourg Europe (ICANS), 17 Rue Albert Calmette, BP 23025, 67033 Strasbourg, France.
Vit C; Clinical Research Unit, Institut de Cancérologie Strasbourg Europe (ICANS), 17 Rue Albert Calmette, BP 23025, 67033 Strasbourg, France.
Le Fèvre C; Department of Radiation Oncology, Institut de Cancérologie Strasbourg Europe (ICANS), 17 Rue Albert Calmette, BP 23025, 67033 Strasbourg, France.
Antoni D; Department of Radiation Oncology, Institut de Cancérologie Strasbourg Europe (ICANS), 17 Rue Albert Calmette, BP 23025, 67033 Strasbourg, France.
Hubele F; Department of Nuclear Medicine, Institut de Cancérologie Strasbourg Europe (ICANS), 17 Rue Albert Calmette, BP 23025, 67033 Strasbourg, France.
Noel G; Department of Radiation Oncology, Institut de Cancérologie Strasbourg Europe (ICANS), 17 Rue Albert Calmette, BP 23025, 67033 Strasbourg, France.; Radiotherapy Department, ICANS, University of Strasbourg, 67098 Strasbourg, France.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2023 Apr 25; Vol. 15 (9). Date of Electronic Publication: 2023 Apr 25.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Final analysis of the phase 3 randomized clinical trial comparing HD201 vs. referent trastuzumab in patients with ERBB2-positive breast cancer treated in the neoadjuvant setting.
Autorzy:
Pivot X; Institute of Cancer Strasbourg, 17 Rue Albert Calmette, 67033, Strasbourg, France. .
Manikhas AG; St Petersburg GBUZ City Clinical Oncology Dispensary, St Petersburg, Russia.
Shamrai V; Vinnytsia Regional Clinical Oncological Dispensary, Vinnytsia, Ukraine.
Dzagnidze G; S. Khechinashvili University Hospital, Tbilisi, Georgia.
Soo Hoo HF; Penang General Hospital, Penang Island, Malaysia.
Kaewkangsadan V; Department of Surgery, Phramongkutklao Hospital, Bangkok, Thailand.
Petrelli F; Oncology Unit, ASST Bergamo Ovest, Bergamo, Trevigilio, Italy.
Villanueva C; Clinique Clementville, Montpellier, Montpellier, France.
Kim J; Prestige BioPharma Ltd, Singapore, Singapore.
Pradhan S; Prestige BioPharma Ltd, Singapore, Singapore.
Jaison L; Prestige BioPharma Ltd, Singapore, Singapore.
Feyaerts P; Prestige BioPharma Ltd, Singapore, Singapore.
Kaufman L; DICE, Naamloze Vennootschap, Dilbeek, Belgium.
Derde MP; DICE, Naamloze Vennootschap, Dilbeek, Belgium.
Deforce F; DICE, Naamloze Vennootschap, Dilbeek, Belgium.
Cox DG; Institute of Cancer Strasbourg, 17 Rue Albert Calmette, 67033, Strasbourg, France.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Jan 31; Vol. 23 (1), pp. 112. Date of Electronic Publication: 2023 Jan 31.
Typ publikacji:
Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article
MeSH Terms:
Breast Neoplasms*/drug therapy
Humans ; Female ; Trastuzumab/therapeutic use ; Neoadjuvant Therapy ; Cyclophosphamide/therapeutic use ; Docetaxel ; Receptor, ErbB-2
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Low-frequency variation near common germline susceptibility loci are associated with risk of Ewing sarcoma.
Autorzy:
Lin SH; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
Sampson JN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
Grünewald TGP; Max-Eder Research Group for Pediatric Sarcoma Biology, Ludwig Maximilians Universität (LMU), Munich, Germany.; Division of Translational Pediatric Sarcoma Research, German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Heidelberg, Germany.; Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany.
Surdez D; Inserm U830, Équipe Labellisés LNCC, PSL Université, Institut Curie, Paris, France.
Reynaud S; SIREDO Oncology Centre, Institut Curie, Paris, France.
Mirabeau O; Inserm U830, Équipe Labellisés LNCC, PSL Université, Institut Curie, Paris, France.; SIREDO Oncology Centre, Institut Curie, Paris, France.
Karlins E; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, United States of America.
Rubio RA; Max-Eder Research Group for Pediatric Sarcoma Biology, Ludwig Maximilians Universität (LMU), Munich, Germany.
Zaidi S; Inserm U830, Équipe Labellisés LNCC, PSL Université, Institut Curie, Paris, France.; SIREDO Oncology Centre, Institut Curie, Paris, France.
Grossetête-Lalami S; Inserm U830, Équipe Labellisés LNCC, PSL Université, Institut Curie, Paris, France.; SIREDO Oncology Centre, Institut Curie, Paris, France.
Ballet S; SIREDO Oncology Centre, Institut Curie, Paris, France.
Lapouble E; SIREDO Oncology Centre, Institut Curie, Paris, France.
Laurence V; SIREDO Oncology Centre, Institut Curie, Paris, France.
Michon J; SIREDO Oncology Centre, Institut Curie, Paris, France.
Pierron G; SIREDO Oncology Centre, Institut Curie, Paris, France.
Kovar H; Children's Cancer Research Institute, St. Anna Kinderkrebsforschung, Vienna, Austria.
Kontny U; Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Uniklinik RWTH Aachen, Aachen, Germany.
González-Neira A; Human Genotyping Unit-CeGen, Human Cancer Genetics Programme, Spanish National Cancer Research Centre, Madrid, Spain.
Alonso J; Unidad de Tumores Solidos Infantiles (IIER-ISCIII) & Centro de Investigación Biomédica en Red de Enfermedades Raras (CB06/07/1009; CIBERER-ISCIII), Instituto de Salud Carlos III, Majadahonda, Spain.
Patino-Garcia A; Laboratory of Pediatrics, University Clinic of Navarra, Program in Solid Tumors, Center for Applied Medical Research (CIMA) and Navarra's Health Research Institute (IdiSNA), Pamplona, Spain.
Corradini N; Institute for Paediatric Haematology and Oncology, Leon Bérard Cancer Centre, University of Lyon, Lyon, France.
Bérard PM; Institute for Paediatric Haematology and Oncology, Leon Bérard Cancer Centre, University of Lyon, Lyon, France.
Miller J; Information Management Services, Inc., Calverton, MD, United States of America.
Freedman ND; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
Rothman N; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
Carter BD; Behavioral and Epidemiology Research Group, American Cancer Society, Atlanta, GA, United States of America.
Dagnall CL; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, United States of America.
Burdett L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, United States of America.
Jones K; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, United States of America.
Manning M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, United States of America.
Wyatt K; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, United States of America.
Zhou W; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, United States of America.
Yeager M; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.; Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, MD, United States of America.
Cox DG; Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France.
Hoover RN; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
Khan J; Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States of America.
Armstrong GT; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN, United States of America.
Leisenring WM; Cancer Prevention and Clinical Statistics Programs, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.
Bhatia S; Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL, United States of America.
Robison LL; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN, United States of America.
Kulozik AE; Department of Pediatric Oncology, Hematology and Immunology and Hopp Children Cancer Center, University of Heidelberg, Heidelberg, Germany.
Kriebel J; Research Unit of Molecular Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.; Institute of Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental Health, Neuherberg, Germany.; German Center for Diabetes Research (DZD), München, Neuherberg, Germany.
Meitinger T; German Research Center for Environmental Health, Institute of Human Genetics, Helmholtz Zentrum München, Neuherberg, Germany.; Institute of Human Genetics, Technische Universität München, Munich, Germany.
Metzler M; Department of Paediatrics and Adolescent Medicine, University Hospital of Erlangen, Erlangen, Germany.
Krumbholz M; Department of Paediatrics and Adolescent Medicine, University Hospital of Erlangen, Erlangen, Germany.
Hartmann W; Division of Translational Pathology, Gerhard-Domagk Institute of Pathology, University Hospital of Münster, Münster, Germany.
Strauch K; Institute of Genetic Epidemiology, LMU Munich, Munich, Germany.
Kirchner T; Institute of Pathology, Faculty of Medicine, LMU Munich, Munich, Germany.
Dirksen U; Pediatrics III, West German Cancer Centre, University Hospital Essen, Essen, Germany.; German Cancer Consortium (DKTK), Center Essen, Heidelberg, Germany.
Mirabello L; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
Tucker MA; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
Tirode F; Inserm U830, Équipe Labellisés LNCC, PSL Université, Institut Curie, Paris, France.; SIREDO Oncology Centre, Institut Curie, Paris, France.
Morton LM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
Chanock SJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
Delattre O; Inserm U830, Équipe Labellisés LNCC, PSL Université, Institut Curie, Paris, France.; SIREDO Oncology Centre, Institut Curie, Paris, France.
Machiela MJ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2020 Sep 03; Vol. 15 (9), pp. e0237792. Date of Electronic Publication: 2020 Sep 03 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Genetic Loci*
Genetic Predisposition to Disease*
Genetic Variation*
Germ Cells/*metabolism
Sarcoma, Ewing/*genetics
Genome-Wide Association Study ; Humans ; Linkage Disequilibrium/genetics ; Odds Ratio ; Polymorphism, Single Nucleotide/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Determinants of folate and vitamin B12 plasma levels in the French E3N-EPIC cohort.
Autorzy:
de Batlle J; International Agency for Research on Cancer (IARC), 150 cours Albert Thomas, 69008, Lyon, France. .
Matejcic M; International Agency for Research on Cancer (IARC), 150 cours Albert Thomas, 69008, Lyon, France.
Chajes V; International Agency for Research on Cancer (IARC), 150 cours Albert Thomas, 69008, Lyon, France.
Moreno-Macias H; Universidad Autónoma Metropolitana, Mexico City, Mexico.
Amadou A; International Agency for Research on Cancer (IARC), 150 cours Albert Thomas, 69008, Lyon, France.
Slimani N; International Agency for Research on Cancer (IARC), 150 cours Albert Thomas, 69008, Lyon, France.
Cox DG; INSERM U1052, Cancer Research Center of Lyon, Centre Léon Bérard, Lyon, France.
Clavel-Chapelon F; Team 9: Lifestyle, Genes and Health: Integrative Trans-generational Epidemiology, Center for Research in Epidemiology and Population Health, Institut National de la Santé et de la Recherche Médicale (INSERM), U1018, Villejuif, France.; Université Paris-Sud, Villejuif, France.; Gustave Roussy Institute, Villejuif, France.
Fagherazzi G; Team 9: Lifestyle, Genes and Health: Integrative Trans-generational Epidemiology, Center for Research in Epidemiology and Population Health, Institut National de la Santé et de la Recherche Médicale (INSERM), U1018, Villejuif, France.; Université Paris-Sud, Villejuif, France.; Gustave Roussy Institute, Villejuif, France.
Romieu I; International Agency for Research on Cancer (IARC), 150 cours Albert Thomas, 69008, Lyon, France.
Pokaż więcej
Źródło:
European journal of nutrition [Eur J Nutr] 2018 Mar; Vol. 57 (2), pp. 751-760. Date of Electronic Publication: 2016 Dec 21.
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
Nutritional Status*
Diet/*adverse effects
Folic Acid/*blood
Folic Acid Deficiency/*etiology
Vitamin B 12/*blood
Vitamin B 12 Deficiency/*etiology
Amino Acid Substitution ; Biomarkers/blood ; Case-Control Studies ; Cohort Studies ; Diet, Healthy ; Female ; Folic Acid Deficiency/blood ; Folic Acid Deficiency/genetics ; Folic Acid Deficiency/prevention & control ; France/epidemiology ; Genetic Association Studies ; Genetic Predisposition to Disease ; Humans ; Methylenetetrahydrofolate Reductase (NADPH2)/genetics ; Middle Aged ; Patient Compliance ; Polymorphism, Single Nucleotide ; Prospective Studies ; Self Report ; Vitamin B 12 Deficiency/blood ; Vitamin B 12 Deficiency/genetics ; Vitamin B 12 Deficiency/prevention & control
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Targeted Sequencing of the Mitochondrial Genome of Women at High Risk of Breast Cancer without Detectable Mutations in BRCA1/2.
Autorzy:
Blein S; INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
Barjhoux L; INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
Damiola F; INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
Dondon MG; Inserm, U900, Paris, France; Institut Curie, Paris, France; Mines ParisTech, Fontainebleau, France.
Eon-Marchais S; Inserm, U900, Paris, France; Institut Curie, Paris, France; Mines ParisTech, Fontainebleau, France.
Marcou M; Inserm, U900, Paris, France.
Caron O; Consultation de Génétique, Département de Médecine, Institut de Cancérologie Gustave Roussy, Villejuif, France.
Lortholary A; Centre Catherine de Sienne, Nantes, France.
Buecher B; Institut Curie, Department of Tumour Biology, Paris, France.
Vennin P; Département de Cancérologie sénologique, CLCC Oscar Lambret, Lille, France.
Berthet P; Centre François Baclesse, Caen, France.
Noguès C; Oncogénétique Clinique, Hôpital René Huguenin/Institut Curie, Saint-Cloud, France.
Lasset C; Université Lyon 1, CNRS UMR5558, Lyon, France; Unité de Prévention et d'Epidémiologie Génétique, Centre Léon Bérard, Lyon, France.
Gauthier-Villars M; Consultation de Génétique, Département de Médecine, Institut de Cancérologie Gustave Roussy, Villejuif, France.
Mazoyer S; INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
Stoppa-Lyonnet D; Consultation de Génétique, Département de Médecine, Institut de Cancérologie Gustave Roussy, Villejuif, France; Institut Curie, INSERM U830, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, France.
Andrieu N; Inserm, U900, Paris, France; Institut Curie, Paris, France; Mines ParisTech, Fontainebleau, France.
Thomas G; Université Lyon 1, INCa-Synergie, Centre Léon Bérard, 28 rue Laennec, Lyon Cedex 08, France.
Sinilnikova OM; INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France; Unité Mixte de Génétique Constitutionnelle des Cancers Fréquents, Hospices Civils de Lyon - Centre Léon Bérard, Lyon, France.
Cox DG; INSERM U1052, CNRS UMR5286, Université Lyon 1, Centre de Recherche en Cancérologie de Lyon, Lyon, France.
Pokaż więcej
Corporate Authors:
GENESIS investigators
Źródło:
PloS one [PLoS One] 2015 Sep 25; Vol. 10 (9), pp. e0136192. Date of Electronic Publication: 2015 Sep 25 (Print Publication: 2015).
Typ publikacji:
Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms:
BRCA1 Protein*
BRCA2 Protein*
Mutation*
Breast Neoplasms/*genetics
Genome, Mitochondrial/*genetics
Mitochondrial Proton-Translocating ATPases/*genetics
Breast Neoplasms/diagnosis ; Female ; High-Throughput Nucleotide Sequencing ; Humans ; Penetrance
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite.
Autorzy:
Grünewald TG; Genetics and Biology of Cancers Unit, Institut Curie, PSL Research University, Paris, France.; INSERM U830, Institut Curie Research Center, Paris, France.
Bernard V; Institut Curie Genomics of Excellence (ICGex) Platform, Institut Curie Research Center, Paris, France.
Gilardi-Hebenstreit P; École Normale Supérieure (ENS), Institut de Biologie de l'ENS (IBENS), INSERM U1024, CNRS UMR8197, Paris, France.
Raynal V; Genetics and Biology of Cancers Unit, Institut Curie, PSL Research University, Paris, France.; INSERM U830, Institut Curie Research Center, Paris, France.; Institut Curie Genomics of Excellence (ICGex) Platform, Institut Curie Research Center, Paris, France.
Surdez D; Genetics and Biology of Cancers Unit, Institut Curie, PSL Research University, Paris, France.; INSERM U830, Institut Curie Research Center, Paris, France.
Aynaud MM; Genetics and Biology of Cancers Unit, Institut Curie, PSL Research University, Paris, France.; INSERM U830, Institut Curie Research Center, Paris, France.
Mirabeau O; Genetics and Biology of Cancers Unit, Institut Curie, PSL Research University, Paris, France.; INSERM U830, Institut Curie Research Center, Paris, France.
Cidre-Aranaz F; Instituto de Investigación de Enfermedades Raras, Instituto de Salud Carlos III, Madrid, Spain.
Tirode F; Genetics and Biology of Cancers Unit, Institut Curie, PSL Research University, Paris, France.; INSERM U830, Institut Curie Research Center, Paris, France.
Zaidi S; Genetics and Biology of Cancers Unit, Institut Curie, PSL Research University, Paris, France.; INSERM U830, Institut Curie Research Center, Paris, France.
Perot G; INSERM U916 Biology of Sarcomas, Institut Bergonié, Bordeaux, France.
Jonker AH; Genetics and Biology of Cancers Unit, Institut Curie, PSL Research University, Paris, France.; INSERM U830, Institut Curie Research Center, Paris, France.
Lucchesi C; Genetics and Biology of Cancers Unit, Institut Curie, PSL Research University, Paris, France.; INSERM U830, Institut Curie Research Center, Paris, France.
Le Deley MC; Département d'Epidémiologie et de Biostatistiques, Institut Gustave Roussy, Villejuif, France.
Oberlin O; Département de Pédiatrie, Institut Gustave Roussy, Villejuif, France.
Marec-Bérard P; Institute for Pediatric Hematology and Oncology, Leon-Bérard Cancer Center, University of Lyon, Lyon, France.
Véron AS; INSERM U1052, Léon-Bérard Cancer Centre, Cancer Research Center of Lyon, Lyon, France.
Reynaud S; Unité Génétique Somatique (UGS), Institut Curie Centre Hospitalier, Paris, France.
Lapouble E; Unité Génétique Somatique (UGS), Institut Curie Centre Hospitalier, Paris, France.
Boeva V; INSERM U900, Bioinformatics, Biostatistics, Epidemiology and Computational Systems Biology of Cancer, Institut Curie Research Center, Paris, France.; Mines ParisTech, Fontainebleau, France.
Rio Frio T; Institut Curie Genomics of Excellence (ICGex) Platform, Institut Curie Research Center, Paris, France.
Alonso J; Instituto de Investigación de Enfermedades Raras, Instituto de Salud Carlos III, Madrid, Spain.
Bhatia S; Institute for Cancer Outcomes and Survivorship, School of Medicine, University of Alabama, Birmingham, Alabama, USA.
Pierron G; Unité Génétique Somatique (UGS), Institut Curie Centre Hospitalier, Paris, France.
Cancel-Tassin G; Centre de Recherche sur les Pathologies Prostatiques (CeRePP)-Laboratory for Urology, Research Team 2, UPMC, Hôpital Tenon, Paris, France.
Cussenot O; Centre de Recherche sur les Pathologies Prostatiques (CeRePP)-Laboratory for Urology, Research Team 2, UPMC, Hôpital Tenon, Paris, France.
Cox DG; INSERM U1052, Léon-Bérard Cancer Centre, Cancer Research Center of Lyon, Lyon, France.
Morton LM; Division of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute (NCI), Bethesda, Maryland, USA.
Machiela MJ; Division of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute (NCI), Bethesda, Maryland, USA.
Chanock SJ; Division of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute (NCI), Bethesda, Maryland, USA.
Charnay P; École Normale Supérieure (ENS), Institut de Biologie de l'ENS (IBENS), INSERM U1024, CNRS UMR8197, Paris, France.
Delattre O; Genetics and Biology of Cancers Unit, Institut Curie, PSL Research University, Paris, France.; INSERM U830, Institut Curie Research Center, Paris, France.; Institut Curie Genomics of Excellence (ICGex) Platform, Institut Curie Research Center, Paris, France.; Unité Génétique Somatique (UGS), Institut Curie Centre Hospitalier, Paris, France.
Pokaż więcej
Źródło:
Nature genetics [Nat Genet] 2015 Sep; Vol. 47 (9), pp. 1073-8. Date of Electronic Publication: 2015 Jul 27.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Bone Neoplasms/*genetics
Early Growth Response Protein 2/*genetics
Oncogene Proteins, Fusion/*genetics
Proto-Oncogene Protein c-fli-1/*genetics
RNA-Binding Protein EWS/*genetics
Sarcoma, Ewing/*genetics
Animals ; Base Sequence ; Bone Neoplasms/pathology ; Carotenoids/genetics ; Cell Line, Tumor ; Cell Proliferation ; Gene Expression ; Gene Expression Regulation, Neoplastic ; Genetic Association Studies ; Genetic Predisposition to Disease ; Humans ; Mice, SCID ; Microsatellite Repeats ; Molecular Sequence Data ; Neoplasm Transplantation ; Oxygenases/genetics ; Polymorphism, Single Nucleotide ; Quantitative Trait Loci ; Sarcoma, Ewing/pathology ; Tumor Burden
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Two new cyclopeptides from the co-culture broth of two marine mangrove fungi and their antifungal activity.
Autorzy:
Huang S; Department of Applied Chemistry, College of Science, South China Agricultural University, Guangzhou 510642, China.
Ding W; Department of Applied Chemistry, College of Science, South China Agricultural University, Guangzhou 510642, China.
Li C; Department of Applied Chemistry, College of Science, South China Agricultural University, Guangzhou 510642, China.
Cox DG; Department of Pharmacognosy and Research, Institute of Pharmaceutical Sciences, School of Pharmacy, The University of Mississippi, Mississippi University, 38677, Mississippi, USA.
Pokaż więcej
Źródło:
Pharmacognosy magazine [Pharmacogn Mag] 2014 Oct; Vol. 10 (40), pp. 410-4.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Influence of multiple APOE genetic variants on cognitive function in a cohort of older men - results from the Normative Aging Study.
Autorzy:
Prada D
Colicino E
Power MC
Cox DG
Weisskopf MG
Hou L
Spiro Iii A
Vokonas P
Zhong J
Sanchez-Guerra M
Herrera LA
Schwartz J
Baccarelli AA; Department of Environmental Health, Harvard School of Public Health, 665 Huntington Ave, Boston 02115, MA, USA. .
Pokaż więcej
Źródło:
BMC psychiatry [BMC Psychiatry] 2014 Aug 01; Vol. 14, pp. 223. Date of Electronic Publication: 2014 Aug 01.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Aging/*psychology
Apolipoproteins E/*genetics
Cognition/*physiology
Adult ; Aged ; Aged, 80 and over ; Cognition Disorders ; Genotype ; Haplotypes ; Humans ; Male ; Middle Aged ; Neuropsychological Tests ; Polymorphism, Genetic ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Mitochondrial haplogroups modify the effect of black carbon on age-related cognitive impairment.
Autorzy:
Colicino E; Department of Environmental Health, Harvard School of Public Health, 665 Huntington Ave, Boston, MA 02115, USA. .
Power MC
Cox DG
Weisskopf MG
Hou L
Alexeeff SE
Sanchez-Guerra M
Vokonas P
Spiro A 3rd
Schwartz J
Baccarelli AA
Pokaż więcej
Źródło:
Environmental health : a global access science source [Environ Health] 2014 May 30; Vol. 13 (1), pp. 42. Date of Electronic Publication: 2014 May 30.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Air Pollutants/*toxicity
Cognition Disorders/*genetics
DNA, Mitochondrial/*genetics
Soot/*toxicity
Vehicle Emissions/*toxicity
Aged ; Aged, 80 and over ; Aging ; Air Pollutants/analysis ; Cognition/drug effects ; Cognition Disorders/chemically induced ; Environmental Exposure/adverse effects ; Environmental Exposure/analysis ; Haplotypes ; Humans ; Male ; Massachusetts ; Middle Aged ; Neuropsychological Tests ; Polymorphism, Genetic ; Soot/analysis ; Vehicle Emissions/analysis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Factors associated with oxidative stress and cancer risk in the Breast and Prostate Cancer Cohort Consortium.
Autorzy:
Blein S; Université de Lyon , Lyon , France.
Berndt S
Joshi AD
Campa D
Ziegler RG
Riboli E
Cox DG
Pokaż więcej
Corporate Authors:
NCI Breast and Prostate Cancer Cohort Consortium
Źródło:
Free radical research [Free Radic Res] 2014 Mar; Vol. 48 (3), pp. 380-6. Date of Electronic Publication: 2014 Jan 23.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Breast Neoplasms/*genetics
Breast Neoplasms/*metabolism
Oxidative Stress/*genetics
Prostatic Neoplasms/*genetics
Prostatic Neoplasms/*metabolism
Female ; Genetic Predisposition to Disease ; Genotype ; Humans ; Male ; Oxidative Stress/physiology ; Polymorphism, Single Nucleotide ; Reactive Oxygen Species/metabolism ; Survival Analysis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 42

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies